FAT1 and cancer: Since elevated CIN is known to synergize with WGD to generate increased intratumour heterogeneity3,45 and escape from targeted therapeutic pressure12,14,46,47, we also investigated whether FAT1 loss might enable WGD PC9 cells to accelerate cancer evolution and bypass targeted therapy treatment.